Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Spliceosome (mmu03040)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
0610009D
07Rik
KLA  ATP  ATP+KLA
 AK034275 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330171D12 product:hypothetical RNA-binding region RNP-1 (RNA recognition motif) containing protein, full insert sequence [AK034275] KLA .95 .92 .88 .86 .98 .89 .90
ATP .80 .70 .67 .75 .93 .92 .97
KLA/ATP .79 .70 .69 .81 .90 .82 1.03
0610009D
07Rik
KLA  ATP  ATP+KLA
 NM_025323 RIKEN cDNA 0610009D07 gene (0610009D07Rik), mRNA [NM_025323] KLA 1.04 1.04 .99 1.05 .98 1.14 1.10
ATP .84 .83 1.14 .94 .95 1.28 .96
KLA/ATP .92 .92 1.18 1.00 1.18 1.17 .89
2610101N
10Rik
KLA  ATP  ATP+KLA
 NM_026476 RIKEN cDNA 2610101N10 gene (2610101N10Rik), transcript variant 2, mRNA [NM_026476] KLA 1.47 1.50 1.38 1.51 1.26 1.18 1.10
ATP 1.04 .97 1.08 .88 1.44 1.17 .98
KLA/ATP 1.49 1.70 1.84 1.14 1.32 1.26 1.15
2610209M
04Rik
KLA  ATP  ATP+KLA
 NM_025665 RIKEN cDNA 2610209M04 gene (2610209M04Rik), mRNA [NM_025665] KLA 1.21 1.13 1.24 1.53 1.42 1.40 1.43
ATP 1.09 .99 1.27 1.12 .87 1.02 1.24
KLA/ATP 1.23 1.22 1.58 1.35 1.21 .96 1.32
Acin1
KLA  ATP  ATP+KLA
 AK042374 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630085P16 product:unclassifiable, full insert sequence [AK042374] KLA 1.46 1.17 1.31 1.19 1.06 1.11 .89
ATP .94 1.04 1.35 1.47 1.30 1.55 .65
KLA/ATP 1.22 1.35 1.57 1.74 1.42 1.69 .87
Acin1
KLA  ATP  ATP+KLA
 NM_023190 apoptotic chromatin condensation inducer 1 (Acin1), transcript variant 2, mRNA [NM_023190] KLA 1.22 1.30 1.00 1.27 1.23 1.18 1.03
ATP 1.02 1.04 .94 .99 1.19 1.36 1.08
KLA/ATP 1.16 1.39 1.47 1.35 1.58 1.43 1.13
Aqr
KLA  ATP  ATP+KLA
 NM_009702 aquarius (Aqr), mRNA [NM_009702] KLA 1.06 1.07 1.10 .96 .90 .98 1.05
ATP .97 1.12 1.09 1.02 .70 .78 .86
KLA/ATP 1.06 1.16 .95 .98 .68 .83 .72
Ascc3l1
KLA  ATP  ATP+KLA
 NM_177214 activating signal cointegrator 1 complex subunit 3-like 1 (Ascc3l1), mRNA [NM_177214] KLA 1.01 .99 1.05 .91 .97 .90 .98
ATP 1.06 1.09 .86 .73 .68 .78 .83
KLA/ATP 1.13 1.06 .81 .70 .56 .78 .75
AU014645
KLA  ATP  ATP+KLA
 NM_001033201 expressed sequence AU014645 (AU014645), mRNA [NM_001033201] KLA .81 .90 .86 .75 .67 .74 .85
ATP 1.01 1.02 1.10 1.08 1.40 1.44 .99
KLA/ATP .83 .85 .89 .80 .81 .99 .73
Bat1a
KLA  ATP  ATP+KLA
 NM_019693 HLA-B-associated transcript 1A (Bat1a), mRNA [NM_019693] KLA 1.15 1.21 1.36 1.17 1.39 1.22 1.07
ATP 1.15 1.27 .91 1.33 1.30 1.23 .92
KLA/ATP 1.41 1.41 .90 1.53 1.07 1.15 1.09
Bcas2
KLA  ATP  ATP+KLA
 NM_026602 breast carcinoma amplified sequence 2 (Bcas2), mRNA [NM_026602] KLA .68 .68 .63 .51 .49 .55 .74
ATP .93 .99 1.23 1.10 .94 .74 .73
KLA/ATP .62 .63 .75 .66 .68 .69 .54
Ccdc12
KLA  ATP  ATP+KLA
 NM_028312 coiled-coil domain containing 12 (Ccdc12), mRNA [NM_028312] KLA .65 .68 .63 .65 .72 .87 1.10
ATP .96 1.02 1.06 1.12 .89 .64 .84
KLA/ATP .64 .67 .72 .75 .83 .76 .93
Cdc40
KLA  ATP  ATP+KLA
 AK040680 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530014E20 product:PRE-MRNA SPLICING FACTOR PRP17 homolog [Mus musculus], full insert sequence. [AK040680] KLA 1.05 1.01 .97 .96 1.18 1.10 1.03
ATP .86 .63 .43 .64 .93 1.04 1.02
KLA/ATP .93 .76 .63 .78 1.00 .85 .97
Cdc40
KLA  ATP  ATP+KLA
 XM_483893 gb|PREDICTED: Mus musculus cell division cycle 40 homolog (yeast), transcript variant 1 (Cdc40), mRNA [XM_483893] KLA 1.40 1.41 1.50 1.27 1.21 1.11 1.28
ATP 1.08 1.21 1.16 1.12 1.17 1.10 .99
KLA/ATP 1.45 1.53 1.20 1.37 1.16 1.40 1.15
Cdc5l
KLA  ATP  ATP+KLA
 NM_152810 cell division cycle 5-like (S. pombe) (Cdc5l), mRNA [NM_152810] KLA .69 .71 .71 .66 .66 .83 .89
ATP .96 .97 1.13 .92 1.17 1.51 1.08
KLA/ATP .66 .68 .79 .65 1.01 1.48 1.10
Cherp
KLA  ATP  ATP+KLA
 NM_138585 calcium homeostasis endoplasmic reticulum protein (Cherp), mRNA [NM_138585] KLA .82 .70 .67 .77 .71 .78 .77
ATP 1.01 .92 1.19 .87 .71 .91 .67
KLA/ATP .72 .71 .88 .61 .63 .79 .50
Crnkl1
KLA  ATP  ATP+KLA
 NM_025820 Crn, crooked neck-like 1 (Drosophila) (Crnkl1), mRNA [NM_025820] KLA 1.25 1.29 1.17 1.16 1.14 1.17 1.14
ATP .99 1.00 .85 .77 1.03 1.46 1.32
KLA/ATP 1.16 1.25 1.05 .98 .98 1.52 1.21
Ctnnbl1
KLA  ATP  ATP+KLA
 NM_025680 catenin, beta like 1 (Ctnnbl1), mRNA [NM_025680] KLA .95 1.03 1.03 .99 .93 .85 .80
ATP .98 .92 1.03 1.08 .94 .73 .78
KLA/ATP 1.00 1.11 1.17 1.12 .97 .81 .72
Cwc15
KLA  ATP  ATP+KLA
 AK013670 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900052N06 product:unclassifiable, full insert sequence. [AK013670] KLA 1.66 1.81 1.52 1.58 1.54 1.36 .91
ATP .67 .62 .38 .64 1.50 1.61 .81
KLA/ATP 1.26 1.30 .93 .92 1.79 1.94 1.01
Cwc15
KLA  ATP  ATP+KLA
 NM_023153 CWC15 homolog (S. cerevisiae) (Cwc15), mRNA [NM_023153] KLA 1.43 1.46 1.51 1.95 1.88 1.73 1.16
ATP 1.01 .95 1.05 .98 1.17 1.58 .99
KLA/ATP 1.37 1.46 1.74 1.45 1.80 2.03 1.45
Ddx23
KLA  ATP  ATP+KLA
 BC049928 DEAD (Asp-Glu-Ala-Asp) box polypeptide 23, mRNA (cDNA clone IMAGE:5321607), complete cds. [BC049928] KLA .88 .85 .87 .82 1.01 .97 1.09
ATP 1.12 .98 .73 .71 1.04 .91 .86
KLA/ATP .83 .85 .71 .77 .92 .84 .74
Ddx23
KLA  ATP  ATP+KLA
 NM_001080981 DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 (Ddx23), mRNA [NM_001080981] KLA 1.00 1.07 1.15 1.13 1.04 1.02 1.18
ATP .92 1.07 1.22 1.06 1.20 .86 1.16
KLA/ATP 1.02 1.24 1.31 1.03 1.13 .96 1.03
Ddx42
KLA  ATP  ATP+KLA
 NM_028074 DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 (Ddx42), mRNA [NM_028074] KLA 1.06 1.01 .91 1.08 1.15 1.23 1.11
ATP .84 .86 1.03 .76 .60 .81 1.00
KLA/ATP .94 1.03 1.05 .94 .74 .80 .97
Ddx46
KLA  ATP  ATP+KLA
 NM_145975 DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 (Ddx46), mRNA [NM_145975] KLA 1.12 1.20 1.05 1.12 .93 .72 .92
ATP 1.00 1.02 1.07 .89 1.03 .96 .67
KLA/ATP 1.17 1.18 1.27 1.02 .92 .65 .54
Ddx5
KLA  ATP  ATP+KLA
 NM_007840 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 (Ddx5), mRNA [NM_007840] KLA 1.36 1.40 1.22 1.23 1.04 1.00 .90
ATP .94 .83 .80 .72 1.35 1.36 .84
KLA/ATP 1.30 1.19 1.09 .94 2.47 1.47 .81
Dhx15
KLA  ATP  ATP+KLA
 AF017153 putative RNA helicase and RNA dependent ATPase (mDEAH9) mRNA, complete cds. [AF017153] KLA 1.21 1.18 1.27 .94 .91 .76 .89
ATP 1.19 1.22 1.05 1.00 1.28 1.42 .90
KLA/ATP 1.31 1.30 .97 .94 1.07 1.21 .76
Dhx15
KLA  ATP  ATP+KLA
 NM_007839 DEAH (Asp-Glu-Ala-His) box polypeptide 15 (Dhx15), transcript variant 2, mRNA [NM_007839] KLA 1.15 1.16 1.10 .91 .84 .78 .88
ATP .99 1.12 1.04 .95 1.19 1.43 .87
KLA/ATP 1.14 1.16 .95 .95 1.03 1.22 .71
Dhx16
KLA  ATP  ATP+KLA
 NM_026987 DEAH (Asp-Glu-Ala-His) box polypeptide 16 (Dhx16), mRNA [NM_026987] KLA 1.04 1.00 .98 .95 1.02 .95 .88
ATP 1.00 .89 .86 .68 .68 1.02 1.04
KLA/ATP 1.01 .89 .84 .69 .72 .97 .99
Dhx38
KLA  ATP  ATP+KLA
 NM_178380 DEAH (Asp-Glu-Ala-His) box polypeptide 38 (Dhx38), mRNA [NM_178380] KLA 1.05 1.08 1.21 1.21 1.47 1.48 1.30
ATP 1.01 1.04 .82 .90 .91 1.30 1.39
KLA/ATP 1.08 1.13 1.06 1.12 1.10 1.98 1.64
Dhx8
KLA  ATP  ATP+KLA
 AK049586 7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430047N04 product:unclassifiable, full insert sequence. [AK049586] KLA .97 .85 .96 .92 .94 .98 .98
ATP .98 .89 .84 .85 1.08 .89 1.03
KLA/ATP .99 .81 .86 .83 .91 .94 .97
Dhx8
KLA  ATP  ATP+KLA
 NM_144831 DEAH (Asp-Glu-Ala-His) box polypeptide 8 (Dhx8), mRNA [NM_144831] KLA 1.06 1.09 1.10 1.11 1.23 1.29 1.51
ATP 1.13 1.30 1.00 1.33 1.31 1.87 2.08
KLA/ATP 1.25 1.16 .77 1.29 .99 2.01 3.68
Eftud2
KLA  ATP  ATP+KLA
 NM_011431 elongation factor Tu GTP binding domain containing 2 (Eftud2), transcript variant 1, mRNA [NM_011431] KLA 1.02 1.05 1.07 .98 1.02 1.03 1.05
ATP .98 1.10 1.02 1.23 .95 .81 1.13
KLA/ATP 1.12 1.10 .98 1.20 .85 .94 1.06
Eif4a3
KLA  ATP  ATP+KLA
 NM_138669 eukaryotic translation initiation factor 4A, isoform 3 (Eif4a3), mRNA [NM_138669] KLA 1.10 1.12 1.03 1.04 .91 .85 .82
ATP .97 1.05 1.00 1.32 1.02 .89 .72
KLA/ATP 1.07 1.13 1.10 1.37 1.06 .87 .52
Fusip1
KLA  ATP  ATP+KLA
 AK161097 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732425P20 product:FUS interacting protein (serine-arginine rich) 1, full insert sequence. [AK161097] KLA .52 .55 .54 .68 .73 .82 .90
ATP 1.04 .90 .62 .67 1.09 .83 .72
KLA/ATP .53 .53 .54 .68 .91 .85 .62
Fusip1
KLA  ATP  ATP+KLA
 NM_001080387 FUS interacting protein (serine-arginine rich) 1 (Fusip1), transcript variant 2, mRNA [NM_001080387] KLA 1.16 1.22 1.20 .96 .82 .97 1.15
ATP 1.00 .96 .73 .73 .64 .76 .90
KLA/ATP 1.26 1.27 .79 .90 .66 .63 .83
Fusip1
KLA  ATP  ATP+KLA
 NM_010178 FUS interacting protein (serine-arginine rich) 1 (Fusip1), transcript variant 1, mRNA [NM_010178] KLA 1.30 1.34 1.20 1.32 1.12 1.13 1.16
ATP .90 .80 .93 .90 1.28 1.54 1.17
KLA/ATP 1.15 1.03 1.16 1.12 1.55 1.38 1.40
Hnrnpa1
KLA  ATP  ATP+KLA
 AK136113 in vitro fertilized eggs cDNA, RIKEN full-length enriched library, clone:7420458G04 product:heterogeneous nuclear ribonucleoprotein A1, full insert sequence. [AK136113] KLA .89 .96 .80 .78 .92 .80 1.13
ATP 1.00 1.03 1.37 1.66 1.70 1.39 .71
KLA/ATP .83 .90 1.09 1.32 1.41 1.21 .78
Hnrnpa1
KLA  ATP  ATP+KLA
 NM_001039129 heterogeneous nuclear ribonucleoprotein A1 (Hnrnpa1), transcript variant 2, mRNA [NM_001039129] KLA 1.17 1.19 1.03 1.14 .87 .70 .52
ATP .90 .92 1.22 1.01 .86 .51 .46
KLA/ATP .97 1.08 1.27 1.16 .94 .59 .15
Hnrnpc
KLA  ATP  ATP+KLA
 AK088678 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430023F13 product:heterogeneous nuclear ribonucleoprotein C, full insert sequence. [AK088678] KLA 1.29 1.33 1.26 1.33 1.30 1.02 .79
ATP 1.21 1.52 1.21 1.58 1.39 1.07 .52
KLA/ATP 1.62 1.69 1.16 1.69 1.04 1.01 .56
Hnrnpc
KLA  ATP  ATP+KLA
 NM_016884 heterogeneous nuclear ribonucleoprotein C (Hnrnpc), mRNA [NM_016884] KLA 1.33 1.41 1.35 1.10 1.15 .89 .81
ATP .98 1.06 1.21 1.69 1.80 1.44 .63
KLA/ATP 1.23 1.46 1.54 1.95 1.73 1.42 .75
Hnrnpu
KLA  ATP  ATP+KLA
 NM_016805 heterogeneous nuclear ribonucleoprotein U (Hnrnpu), mRNA [NM_016805] KLA .76 .72 .65 .69 .71 .78 .88
ATP 1.06 .89 .60 .54 .55 .81 .83
KLA/ATP .70 .69 .54 .44 .50 .53 .66
Hnrpa3
KLA  ATP  ATP+KLA
 NM_146130 heterogeneous nuclear ribonucleoprotein A3 (Hnrpa3), transcript variant b, mRNA [NM_146130] KLA .92 .87 .76 .92 .73 .62 .66
ATP .93 .93 1.02 .84 .66 .38 .49
KLA/ATP .81 .90 1.01 .71 .68 .29 .27
Hnrpk
KLA  ATP  ATP+KLA
 BC089328 heterogeneous nuclear ribonucleoprotein K, mRNA (cDNA clone MGC:102032 IMAGE:6402614), complete cds [BC089328] KLA 1.05 1.04 .97 1.01 .99 .91 .81
ATP 1.04 1.11 1.08 1.11 1.09 .86 .74
KLA/ATP 1.02 .98 .86 .95 .91 .71 .56
Hnrpk
KLA  ATP  ATP+KLA
 NM_025279 heterogeneous nuclear ribonucleoprotein K (Hnrpk), mRNA [NM_025279] KLA 1.14 1.14 1.21 1.15 1.02 1.00 .91
ATP .93 1.13 1.22 1.16 1.06 .89 .87
KLA/ATP .99 1.24 1.34 1.17 .97 .91 .71
Hnrpm
KLA  ATP  ATP+KLA
 NM_029804 heterogeneous nuclear ribonucleoprotein M (Hnrpm), transcript variant 1, mRNA [NM_029804] KLA 1.30 1.14 1.09 1.16 1.08 .82 .72
ATP 1.07 .99 1.28 .90 .98 1.14 .90
KLA/ATP 1.12 1.14 1.59 1.10 1.18 1.06 .83
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Isy1
KLA  ATP  ATP+KLA
 NM_133934 ISY1 splicing factor homolog (S. cerevisiae) (Isy1), mRNA [NM_133934] KLA 1.04 1.11 1.06 1.29 1.23 .90 .97
ATP 1.00 .94 1.04 1.00 1.18 2.21 2.36
KLA/ATP 1.05 1.06 1.14 .94 1.12 3.05 3.48
LOC38409
1
KLA  ATP  ATP+KLA
 BY719776 gb|BY719776 RIKEN full-length enriched, in vitro fertilized eggs Mus musculus cDNA clone 7420424A12 5. [BY719776] KLA 1.17 1.21 1.13 1.34 1.15 .94 .65
ATP .90 .96 1.26 1.39 1.43 1.28 .57
KLA/ATP 1.05 1.18 1.54 1.65 1.67 1.26 .36
Lsm2
KLA  ATP  ATP+KLA
 NM_030597 LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm2), transcript variant 1, mRNA [NM_030597] KLA .83 .80 .81 .74 .57 .52 .58
ATP 1.09 1.08 1.07 1.27 .85 .67 .38
KLA/ATP .90 .92 .84 .89 .68 .52 .36
Lsm3
KLA  ATP  ATP+KLA
 NM_026309 LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm3), mRNA [NM_026309] KLA .95 .94 1.01 .96 1.08 1.14 .74
ATP 1.03 .99 1.42 1.26 .99 1.08 .72
KLA/ATP .97 .91 1.47 1.21 1.27 1.05 .83
Lsm4
KLA  ATP  ATP+KLA
 NM_015816 LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm4), mRNA [NM_015816] KLA .93 .95 .86 .90 .77 .72 .64
ATP 1.01 .96 1.06 1.12 1.03 .68 .49
KLA/ATP .96 .91 1.03 1.04 1.00 .74 .31
Lsm5
KLA  ATP  ATP+KLA
 NM_025520 LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm5), mRNA [NM_025520] KLA 1.06 .97 .96 1.00 .75 .52 .47
ATP .91 1.03 1.36 1.42 1.09 .76 .44
KLA/ATP .94 1.06 1.25 1.38 1.11 .73 .34
Lsm6
KLA  ATP  ATP+KLA
 NM_030145 LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm6), mRNA [NM_030145] KLA 1.17 1.13 1.02 1.10 .84 .69 .62
ATP .87 .89 1.11 1.02 .96 .97 .73
KLA/ATP 1.01 1.15 1.33 1.05 1.02 .90 .58
Lsm7
KLA  ATP  ATP+KLA
 NM_025349 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm7), mRNA [NM_025349] KLA .77 .78 .73 .73 .64 .61 .72
ATP .89 .90 1.14 1.23 .94 .57 .61
KLA/ATP .77 .76 1.00 1.00 .94 .58 .30
Lsm8
KLA  ATP  ATP+KLA
 NM_133939 LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm8), mRNA [NM_133939] KLA 1.04 1.09 1.16 1.19 1.05 1.02 .78
ATP .94 .98 1.23 1.14 .80 .73 .54
KLA/ATP .99 1.11 1.42 1.47 .87 .59 .57
Magoh
KLA  ATP  ATP+KLA
 NM_010760 mago-nashi homolog, proliferation-associated (Drosophila) (Magoh), mRNA [NM_010760] KLA 1.12 1.03 .95 1.10 .90 .96 1.00
ATP .87 .84 1.20 1.06 1.10 1.41 .87
KLA/ATP .93 1.08 1.38 1.10 1.28 1.26 .80
Magohb
KLA  ATP  ATP+KLA
 NM_025564 mago-nashi homolog B (Drosophila) (Magohb), mRNA [NM_025564] KLA 5.18 5.54 4.96 6.10 2.81 2.36 2.86
ATP 1.05 .91 1.21 1.09 .98 1.82 .74
KLA/ATP 5.19 5.26 7.78 5.60 1.78 2.08 1.38
Mm.24042
KLA  ATP  ATP+KLA
 142366948 Unknown KLA .70 .66 .55 .53 .54 .62 .39
ATP .91 .84 1.19 .96 1.32 1.49 .31
KLA/ATP .63 .61 .82 .83 1.11 1.28 .19
Mm.28694
KLA  ATP  ATP+KLA
 141802913 Unknown KLA 1.00 .98 1.03 .95 .87 .93 .87
ATP .98 1.04 .93 .90 .95 .99 .86
KLA/ATP 1.00 1.02 .97 .85 .86 .85 .84
Mm.32892
8
KLA  ATP  ATP+KLA
 158508644 Unknown KLA .64 .65 .65 .67 .71 .71 .71
ATP 1.02 1.12 .94 1.11 .67 .83 .74
KLA/ATP .64 .70 .67 .81 .63 .84 .63
Mm.3757
KLA  ATP  ATP+KLA
 115583686 Unknown KLA .92 .81 .82 .78 .71 .73 .71
ATP .89 .82 .93 .52 .64 .71 .63
KLA/ATP .81 .77 .81 .46 .61 .62 .49
Mm.38065
1
KLA  ATP  ATP+KLA
 158631193 Unknown KLA .85 .83 .86 .91 .83 .88 .87
ATP .92 .89 1.03 .89 .75 .79 .85
KLA/ATP .85 .86 .96 .81 .79 .71 .76
Mm.39284
3
KLA  ATP  ATP+KLA
 118129857 Unknown KLA 1.02 1.15 .83 1.12 .78 .83 .81
ATP .77 1.08 1.11 1.18 .98 .89 .57
KLA/ATP .91 1.20 1.39 1.13 1.17 .84 .53
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.46063
KLA  ATP  ATP+KLA
 149260819 Unknown KLA 1.41 1.35 1.37 1.34 1.27 1.10 1.22
ATP 1.04 1.16 1.10 1.15 1.26 .97 .95
KLA/ATP 1.36 1.48 1.34 1.34 1.24 1.18 1.16
Mm.6787
KLA  ATP  ATP+KLA
 141803005 Unknown KLA 1.61 1.47 1.55 1.58 1.05 .84 .73
ATP .97 .75 1.10 .72 .49 .73 .36
KLA/ATP 1.50 1.31 1.60 1.03 .91 .64 .30
Ncbp2
KLA  ATP  ATP+KLA
 NM_026554 nuclear cap binding protein subunit 2 (Ncbp2), mRNA [NM_026554] KLA .77 .78 .81 .78 .75 .81 1.04
ATP .93 .93 1.01 1.00 .72 .57 1.15
KLA/ATP .78 .82 .91 .85 .71 .49 .63
Nhp2l1
KLA  ATP  ATP+KLA
 NM_011482 NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) (Nhp2l1), mRNA [NM_011482] KLA 1.04 1.06 1.01 .87 .77 .62 .87
ATP .96 1.01 1.02 1.00 .76 .67 .69
KLA/ATP 1.04 1.11 1.02 .96 .74 .51 .39
Nhp2l1
KLA  ATP  ATP+KLA
 U95114 fertilization antigen-1 mRNA, complete cds. [U95114] KLA 1.26 1.30 1.18 1.20 .93 .80 .91
ATP .95 .98 1.23 1.29 1.16 1.04 .71
KLA/ATP 1.21 1.24 1.50 1.50 1.36 .95 .53
Pcbp1
KLA  ATP  ATP+KLA
 NM_011865 poly(rC) binding protein 1 (Pcbp1), mRNA [NM_011865] KLA 1.27 1.14 1.12 1.14 1.01 1.08 .98
ATP .96 .87 1.17 1.43 1.60 1.65 .96
KLA/ATP 1.05 1.06 1.31 1.30 1.69 1.55 1.02
Phf5a
KLA  ATP  ATP+KLA
 NM_026737 PHD finger protein 5A (Phf5a), mRNA [NM_026737] KLA .78 .77 .74 .78 .85 1.02 1.04
ATP .93 1.01 .97 1.05 1.02 1.38 1.10
KLA/ATP .76 .81 .77 .86 .89 1.18 1.19
Plrg1
KLA  ATP  ATP+KLA
 NM_016784 pleiotropic regulator 1, PRL1 homolog (Arabidopsis) (Plrg1), mRNA [NM_016784] KLA 1.08 1.13 1.19 1.17 1.10 1.16 1.06
ATP .99 1.04 .98 1.13 1.02 1.25 1.01
KLA/ATP 1.08 1.17 1.08 1.23 1.13 1.32 1.13
Ppie
KLA  ATP  ATP+KLA
 NM_019489 peptidylprolyl isomerase E (cyclophilin E) (Ppie), mRNA [NM_019489] KLA 1.46 1.40 1.43 1.38 1.33 1.00 1.07
ATP 1.09 1.17 1.28 1.54 1.33 .80 .78
KLA/ATP 1.42 1.53 1.63 2.05 1.57 1.02 .77
Ppih
KLA  ATP  ATP+KLA
 NM_028677 peptidyl prolyl isomerase H (Ppih), transcript variant 1, mRNA [NM_028677] KLA 1.01 .93 .88 .96 .78 .77 .53
ATP .87 .88 1.29 1.29 1.10 .98 .58
KLA/ATP .89 .96 1.30 1.14 1.19 1.09 .59
Ppil1
KLA  ATP  ATP+KLA
 NM_026845 peptidylprolyl isomerase (cyclophilin)-like 1 (Ppil1), mRNA [NM_026845] KLA .58 .57 .57 .60 .63 .65 .62
ATP 1.10 1.03 .96 1.01 .62 .94 .68
KLA/ATP .60 .65 .71 .61 .62 .88 .57
Pqbp1
KLA  ATP  ATP+KLA
 NM_019478 polyglutamine binding protein 1 (Pqbp1), mRNA [NM_019478] KLA .87 1.01 .99 .89 .89 .83 .94
ATP .99 1.18 1.09 1.66 1.30 .97 .99
KLA/ATP .97 1.12 1.03 1.48 1.13 .92 .88
Prpf18
KLA  ATP  ATP+KLA
 NM_026045 PRP18 pre-mRNA processing factor 18 homolog (yeast) (Prpf18), mRNA [NM_026045] KLA 1.55 1.45 1.63 1.50 1.23 1.14 .99
ATP 1.03 1.00 .95 .76 .98 1.20 .96
KLA/ATP 1.42 1.53 1.71 1.11 1.08 1.24 1.01
Prpf19
KLA  ATP  ATP+KLA
 NM_134129 PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae) (Prpf19), mRNA [NM_134129] KLA .85 .99 .95 .81 .66 .70 .75
ATP 1.01 1.19 .67 .75 .58 .58 .52
KLA/ATP 1.03 1.10 .77 .74 .53 .43 .42
Prpf3
KLA  ATP  ATP+KLA
 NM_027541 PRP3 pre-mRNA processing factor 3 homolog (yeast) (Prpf3), mRNA [NM_027541] KLA 1.03 1.08 1.10 1.07 1.09 1.10 1.08
ATP .97 .98 1.19 1.12 1.64 2.06 1.27
KLA/ATP 1.06 1.09 1.18 1.14 1.66 2.01 1.42
Prpf31
KLA  ATP  ATP+KLA
 NM_027328 PRP31 pre-mRNA processing factor 31 homolog (yeast) (Prpf31), mRNA [NM_027328] KLA 1.22 1.28 1.21 1.18 1.18 1.03 1.02
ATP .99 1.02 1.11 1.22 .76 .73 1.08
KLA/ATP 1.18 1.26 1.36 1.49 1.14 .79 .79
Prpf38a
KLA  ATP  ATP+KLA
 AK031401 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030423J02 product:weakly similar to CDNA FLJ14936 FIS, CLONE PLACE1010194, WEAKLY SIMILAR TO SPLICING FACTOR, ARGININE/SERINE-RICH 2 [Homo sapiens], full insert s KLA 1.93 2.13 1.85 1.66 1.75 1.40 .99
ATP .98 .99 .88 .84 1.00 1.12 .82
KLA/ATP 1.93 1.69 1.48 1.34 1.55 1.32 1.00
Prpf38a
KLA  ATP  ATP+KLA
 NM_172697 PRP38 pre-mRNA processing factor 38 (yeast) domain containing A (Prpf38a), mRNA [NM_172697] KLA 6.16 6.53 6.50 6.45 4.99 4.26 2.22
ATP .94 .86 .84 .65 .89 1.71 1.26
KLA/ATP 5.74 5.88 6.40 5.14 3.87 4.19 3.11
Prpf38b
KLA  ATP  ATP+KLA
 NM_025845 PRP38 pre-mRNA processing factor 38 (yeast) domain containing B (Prpf38b), mRNA [NM_025845] KLA 1.63 1.72 1.68 1.89 1.88 1.78 1.50
ATP 1.24 1.30 1.27 1.49 2.05 1.35 1.01
KLA/ATP 1.88 2.16 2.66 2.61 2.64 1.34 1.92
Prpf4
KLA  ATP  ATP+KLA
 NM_027297 PRP4 pre-mRNA processing factor 4 homolog (yeast) (Prpf4), mRNA [NM_027297] KLA 3.12 3.13 3.19 2.92 2.30 2.35 1.00
ATP .98 .97 1.01 .80 .98 1.74 1.14
KLA/ATP 2.80 3.10 3.56 2.58 1.81 2.50 1.60
Prpf40a
KLA  ATP  ATP+KLA
 NM_018785 PRP40 pre-mRNA processing factor 40 homolog A (yeast) (Prpf40a), mRNA [NM_018785] KLA 1.44 1.46 1.50 1.34 1.20 1.15 1.17
ATP .95 1.11 1.22 1.15 1.11 1.11 .93
KLA/ATP 1.41 1.50 1.56 1.47 1.19 1.11 .86
Prpf40b
KLA  ATP  ATP+KLA
 NM_018786 PRP40 pre-mRNA processing factor 40 homolog B (yeast) (Prpf40b), mRNA [NM_018786] KLA 1.13 1.09 1.04 1.01 1.07 1.03 1.15
ATP .98 1.05 .98 .87 .64 .95 1.07
KLA/ATP 1.04 1.09 .96 .88 .84 .96 .91
Prpf6
KLA  ATP  ATP+KLA
 BC025030 PRP6 pre-mRNA splicing factor 6 homolog (yeast), mRNA (cDNA clone MGC:36967 IMAGE:4947416), complete cds. [BC025030] KLA .96 .94 .94 .89 1.01 1.02 .97
ATP .99 .96 .91 .85 1.00 .94 .97
KLA/ATP .90 .96 .93 .96 .93 .86 .96
Prpf6
KLA  ATP  ATP+KLA
 NM_133701 PRP6 pre-mRNA splicing factor 6 homolog (yeast) (Prpf6), mRNA [NM_133701] KLA .86 .91 .87 .89 .93 .94 .91
ATP 1.00 .95 .90 .82 .66 .88 .92
KLA/ATP .93 .93 .90 .78 .73 .88 .95
Prpf8
KLA  ATP  ATP+KLA
 NM_138659 pre-mRNA processing factor 8 (Prpf8), mRNA [NM_138659] KLA .88 .95 .98 .77 .84 .78 .82
ATP 1.12 1.18 .80 .74 .79 .67 .67
KLA/ATP 1.15 .95 .62 .68 .56 .65 .55
Puf60
KLA  ATP  ATP+KLA
 AK013342 10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810454F19 product:hypothetical protein, full insert sequence. [AK013342] KLA .82 .90 .81 .83 1.06 .91 1.00
ATP .47 .55 .85 1.22 1.29 1.19 .94
KLA/ATP .46 .48 .78 1.21 1.04 1.00 1.02
Puf60
KLA  ATP  ATP+KLA
 NM_028364 poly-U binding splicing factor 60 (Puf60), transcript variant 1, mRNA [NM_028364] KLA .91 .99 .95 .87 .92 .87 1.09
ATP 1.10 1.20 .93 1.31 1.17 .99 .97
KLA/ATP 1.03 1.07 .77 1.12 .89 .95 .81
Rbm17
KLA  ATP  ATP+KLA
 NM_152824 RNA binding motif protein 17 (Rbm17), mRNA [NM_152824] KLA 1.42 1.44 1.42 1.40 1.10 .94 .95
ATP .91 .89 .75 .70 .84 1.15 .85
KLA/ATP 1.33 1.33 1.27 1.05 1.05 1.11 .70
Rbm22
KLA  ATP  ATP+KLA
 NM_025776 RNA binding motif protein 22 (Rbm22), mRNA [NM_025776] KLA 1.51 1.46 1.51 1.34 1.38 1.13 1.15
ATP 1.08 1.22 1.00 1.22 1.22 1.23 1.06
KLA/ATP 1.61 1.63 1.15 1.69 1.27 1.49 1.32
Rbm25
KLA  ATP  ATP+KLA
 BC010792 RNA binding motif protein 25, mRNA (cDNA clone IMAGE:4218967), complete cds. [BC010792] KLA 1.05 .98 1.00 .92 1.06 .96 1.09
ATP .95 .95 .84 .93 1.02 .84 1.05
KLA/ATP 1.02 .94 .85 .93 .95 .96 .99
Rbm25
KLA  ATP  ATP+KLA
 BC023749 RIKEN cDNA 2600011C06 gene, mRNA (cDNA clone IMAGE:5354346). [BC023749] KLA 1.48 1.17 1.01 1.03 1.34 1.23 .97
ATP .62 .34 .37 .51 1.07 .85 .94
KLA/ATP .87 .61 .50 .48 .92 .73 .88
Rbm25
KLA  ATP  ATP+KLA
 NM_027349 RNA binding motif protein 25 (Rbm25), mRNA [NM_027349] KLA 1.34 1.12 1.08 1.15 1.04 1.01 .99
ATP 1.18 1.12 1.56 1.59 2.50 1.39 .87
KLA/ATP 1.30 1.38 1.80 1.51 2.37 1.39 .78
Rbm8a
KLA  ATP  ATP+KLA
 NM_025875 RNA binding motif protein 8a (Rbm8a), transcript variant 2, mRNA [NM_025875] KLA 1.11 1.17 1.05 1.17 1.09 1.08 1.01
ATP 1.00 1.07 1.04 1.17 1.00 1.04 .83
KLA/ATP 1.05 1.13 1.24 1.21 1.18 1.10 .91
Rbmx
KLA  ATP  ATP+KLA
 AJ237846 mRNA for heterogeneous nuclear ribonucleoprotein G, splice variant 2. [AJ237846] KLA .48 .51 .57 .52 .59 .60 .63
ATP .64 .50 .61 .72 .70 .62 .61
KLA/ATP .42 .41 .63 .88 .67 .50 .44
Rbmx
KLA  ATP  ATP+KLA
 NM_011252 RNA binding motif protein, X chromosome (Rbmx), mRNA [NM_011252] KLA 1.14 1.23 1.18 1.14 1.19 1.05 1.11
ATP 1.07 1.31 1.14 1.50 .97 .63 1.01
KLA/ATP 1.21 1.33 .99 1.71 1.06 .79 1.26
Rbmxl2
KLA  ATP  ATP+KLA
 NM_029660 RNA binding motif protein, X-linked-like 2 (Rbmxl2), mRNA [NM_029660] KLA .93 .89 .94 .95 .91 .92 1.08
ATP .98 .97 .83 .94 .99 1.00 1.19
KLA/ATP 1.01 .91 .87 .92 .91 .96 1.17
Rbmxrt
KLA  ATP  ATP+KLA
 NM_009033 RNA binding motif protein, X chromosome retrogene (Rbmxrt), mRNA [NM_009033] KLA .92 .89 .94 .78 .70 .68 .69
ATP .96 1.02 1.03 .85 .76 .88 .61
KLA/ATP .90 .89 .93 .79 .73 .74 .41
Refbp2
KLA  ATP  ATP+KLA
 NM_019484 RNA and export factor binding protein 2 (Refbp2), mRNA [NM_019484] KLA 1.09 1.18 1.13 1.20 1.12 1.09 .84
ATP 1.02 1.07 1.07 1.66 1.44 1.03 .68
KLA/ATP 1.12 1.25 1.19 1.74 1.49 .94 .62
Sart1
KLA  ATP  ATP+KLA
 NM_016882 squamous cell carcinoma antigen recognized by T-cells 1 (Sart1), mRNA [NM_016882] KLA .93 1.03 .96 .98 1.02 1.01 .93
ATP .94 .98 .97 1.08 1.14 1.21 1.09
KLA/ATP .99 1.05 1.09 1.15 1.22 1.15 1.09
Sf3a1
KLA  ATP  ATP+KLA
 NM_026175 splicing factor 3a, subunit 1 (Sf3a1), mRNA [NM_026175] KLA .88 .89 .89 .91 .98 .98 .84
ATP 1.00 1.09 1.10 1.14 1.23 1.05 .75
KLA/ATP .90 .94 .83 1.00 1.28 1.19 .72
Sf3a2
KLA  ATP  ATP+KLA
 NM_013651 splicing factor 3a, subunit 2 (Sf3a2), mRNA [NM_013651] KLA 1.04 1.12 1.12 .99 .99 1.09 1.10
ATP 1.09 1.26 .96 1.57 1.13 1.02 1.06
KLA/ATP 1.20 1.19 .86 1.35 .87 1.03 1.11
Sf3a3
KLA  ATP  ATP+KLA
 NM_029157 splicing factor 3a, subunit 3 (Sf3a3), mRNA [NM_029157] KLA 1.30 1.32 1.16 1.35 1.00 .97 .94
ATP .96 .84 1.04 .88 .76 1.14 .85
KLA/ATP 1.22 1.29 1.54 1.36 1.29 1.06 .72
Sf3b1
KLA  ATP  ATP+KLA
 NM_031179 splicing factor 3b, subunit 1 (Sf3b1), mRNA [NM_031179] KLA 1.40 1.43 1.30 1.25 1.19 1.14 .87
ATP 1.01 .95 1.07 1.18 1.16 .96 .62
KLA/ATP 1.49 1.34 1.45 1.34 1.19 .96 .68
Sf3b2
KLA  ATP  ATP+KLA
 NM_030109 splicing factor 3b, subunit 2 (Sf3b2), mRNA [NM_030109] KLA .86 .91 .95 .86 .93 .88 .88
ATP 1.05 1.03 .94 1.07 .91 .61 .81
KLA/ATP .91 .91 .84 .89 .76 .72 .72
Sf3b3
KLA  ATP  ATP+KLA
 AK017529 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730409A01 product:hypothetical protein, full insert sequence. [AK017529] KLA .89 .83 .73 .76 .85 .78 .82
ATP .89 .73 .78 .83 1.38 1.23 .93
KLA/ATP .62 .65 .75 .87 1.05 .94 .69
Sf3b3
KLA  ATP  ATP+KLA
 NM_133953 splicing factor 3b, subunit 3 (Sf3b3), mRNA [NM_133953] KLA 1.30 1.34 1.36 1.17 .96 .82 .83
ATP .95 1.08 .98 .90 .96 1.22 .89
KLA/ATP 1.40 1.51 1.28 1.12 .88 1.01 .68
Sf3b4
KLA  ATP  ATP+KLA
 NM_153053 splicing factor 3b, subunit 4 (Sf3b4), mRNA [NM_153053] KLA .97 .86 .78 .84 .75 .76 .87
ATP 1.08 1.09 1.15 1.35 1.26 1.47 1.23
KLA/ATP .81 .90 .85 1.11 1.10 1.35 1.26
Sf3b5
KLA  ATP  ATP+KLA
 AK035884 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630013P17 product:unclassifiable, full insert sequence [AK035884] KLA 1.05 1.00 1.02 .99 1.07 1.09 1.01
ATP 1.06 .99 .91 .94 .97 1.00 1.01
KLA/ATP .99 1.00 .90 .96 .97 .91 1.00
Sf3b5
KLA  ATP  ATP+KLA
 NM_175102 splicing factor 3b, subunit 5 (Sf3b5), mRNA [NM_175102] KLA .97 .97 .95 .94 .87 .75 .74
ATP 1.08 1.04 1.17 1.31 1.23 .86 .71
KLA/ATP 1.02 1.06 1.31 1.18 1.26 .95 .64
Sfrs1
KLA  ATP  ATP+KLA
 NM_001078167 splicing factor, arginine/serine-rich 1 (ASF/SF2) (Sfrs1), transcript variant 2, mRNA [NM_001078167] KLA .75 .76 .66 .60 .57 .64 .73
ATP 1.06 1.10 .93 .82 .68 .72 .70
KLA/ATP .87 .71 .61 .60 .37 .37 .42
Sfrs1
KLA  ATP  ATP+KLA
 NM_173374 splicing factor, arginine/serine-rich 1 (ASF/SF2) (Sfrs1), transcript variant 1, mRNA [NM_173374] KLA 1.10 1.24 1.10 1.04 .80 .84 1.04
ATP .97 1.19 .95 1.43 .92 .94 .87
KLA/ATP 1.17 1.18 .97 1.24 .75 .76 .79
Sfrs10
KLA  ATP  ATP+KLA
 BC057996 splicing factor, arginine/serine-rich 10 (transformer 2 homolog, Drosophila), mRNA (cDNA clone IMAGE:5343672). [BC057996] KLA 1.29 1.25 1.34 1.91 1.81 1.54 1.19
ATP 1.09 1.04 2.53 2.84 2.66 1.98 1.15
KLA/ATP 1.44 1.63 4.25 3.50 3.86 2.09 1.60
Sfrs10
KLA  ATP  ATP+KLA
 NM_009186 splicing factor, arginine/serine-rich 10 (transformer 2 homolog, Drosophila) (Sfrs10), mRNA [NM_009186] KLA 1.86 1.67 2.02 1.75 .95 .70 .86
ATP 1.13 1.07 1.15 1.20 1.19 1.01 .70
KLA/ATP 1.97 1.81 2.15 1.95 1.36 .88 .60
Sfrs2
KLA  ATP  ATP+KLA
 NM_011358 splicing factor, arginine/serine-rich 2 (SC-35) (Sfrs2), mRNA [NM_011358] KLA .73 .79 .69 .68 .96 1.39 .79
ATP 1.09 1.18 1.00 1.59 .94 .65 .84
KLA/ATP .74 .82 .60 1.18 .83 .73 .75
Sfrs2
KLA  ATP  ATP+KLA
 U14648 putative myelin regulatory factor 1 mRNA, partial cds. [U14648] KLA .62 .66 .59 .59 .82 1.27 .75
ATP .99 1.01 .96 1.26 .86 .58 .69
KLA/ATP .61 .64 .54 .85 .76 .68 .66
Sfrs3
KLA  ATP  ATP+KLA
 NM_013663 splicing factor, arginine/serine-rich 3 (SRp20) (Sfrs3), mRNA [NM_013663] KLA 1.54 1.52 1.30 1.45 1.06 .86 .70
ATP .96 .85 1.07 .65 .51 .74 .38
KLA/ATP 1.52 1.22 1.56 1.08 .84 .58 .34
Sfrs4
KLA  ATP  ATP+KLA
 NM_020587 splicing factor, arginine/serine-rich 4 (SRp75) (Sfrs4), mRNA [NM_020587] KLA 1.33 1.18 1.18 1.02 1.09 1.03 .91
ATP 1.06 1.00 .70 .80 1.35 1.34 .90
KLA/ATP 1.33 1.22 .85 .90 1.45 1.69 1.04
Sfrs5
KLA  ATP  ATP+KLA
 NM_001079695 splicing factor, arginine/serine-rich 5 (SRp40, HRS) (Sfrs5), transcript variant 1, mRNA [NM_001079695] KLA 1.38 1.62 1.21 1.26 1.95 1.98 .95
ATP .67 .64 .50 .45 .67 3.70 .90
KLA/ATP 1.28 1.23 1.01 .81 .86 2.20 1.22
Sfrs6
KLA  ATP  ATP+KLA
 AK004831 adult male lung cDNA, RIKEN full-length enriched library, clone:1210001E11 product:SPLICING FACTOR, ARGININE/SERINE-RICH 6 homolog [Homo sapiens], full insert sequence. [AK004831] KLA 1.05 1.09 .91 .69 .76 .79 1.01
ATP 1.06 1.01 .83 .70 .64 1.36 1.16
KLA/ATP 1.16 .99 .76 .72 .42 .83 .67
Sfrs7
KLA  ATP  ATP+KLA
 NM_146083 splicing factor, arginine/serine-rich 7 (Sfrs7), mRNA [NM_146083] KLA 1.39 1.34 1.35 1.29 1.09 .94 .74
ATP .93 .81 1.07 1.16 .90 1.29 .54
KLA/ATP 1.32 1.32 1.63 1.50 1.23 1.51 .53
Sfrs9
KLA  ATP  ATP+KLA
 NM_025573 splicing factor, arginine/serine rich 9 (Sfrs9), mRNA [NM_025573] KLA .63 .63 .60 .65 .86 1.19 1.07
ATP .97 1.01 .90 .91 .61 .61 .85
KLA/ATP .65 .72 .53 .54 .46 .54 .77
Slu7
KLA  ATP  ATP+KLA
 NM_148673 SLU7 splicing factor homolog (S. cerevisiae) (Slu7), transcript variant 1, mRNA [NM_148673] KLA 1.20 1.20 1.15 1.44 1.31 1.27 1.15
ATP .87 .76 .65 .55 .76 1.14 .89
KLA/ATP 1.03 .97 .98 .79 1.29 1.44 .97
Smndc1
KLA  ATP  ATP+KLA
 NM_172429 survival motor neuron domain containing 1 (Smndc1), mRNA [NM_172429] KLA 1.43 1.32 1.30 1.24 1.19 1.14 1.09
ATP 1.03 .92 1.04 1.04 1.75 2.01 1.02
KLA/ATP 1.37 1.29 1.33 1.20 1.80 1.90 1.31
Snrp70
KLA  ATP  ATP+KLA
 AK077425 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730406H19 product:U1 small nuclear ribonucleoprotein 70 kDa polypeptide A, full insert sequence [AK077425] KLA .82 .79 .81 .69 .77 .63 .58
ATP .87 .80 .55 .51 1.12 .99 .90
KLA/ATP .79 .67 .54 .55 .85 .82 .72
Snrp70
KLA  ATP  ATP+KLA
 NM_009224 U1 small nuclear ribonucleoprotein polypeptide A (Snrp70), mRNA [NM_009224] KLA .93 1.00 .87 .89 .86 .83 .85
ATP .95 .99 .81 .69 .87 1.27 1.07
KLA/ATP .90 .93 .86 .72 .88 1.05 .86
Snrpa
KLA  ATP  ATP+KLA
 NM_015782 small nuclear ribonucleoprotein polypeptide A (Snrpa), transcript variant 1, mRNA [NM_015782] KLA .75 .78 .67 .64 .85 .98 1.01
ATP 1.00 1.04 .65 .93 .66 .64 1.11
KLA/ATP .85 .73 .47 .69 .51 .61 .80
Snrpa1
KLA  ATP  ATP+KLA
 NM_021336 small nuclear ribonucleoprotein polypeptide A (Snrpa1), mRNA [NM_021336] KLA 1.08 1.12 1.00 .99 .84 .71 1.00
ATP .91 .93 1.05 1.00 .96 .82 .64
KLA/ATP .99 1.07 1.19 .99 .92 .57 .39
Snrpb
KLA  ATP  ATP+KLA
 NM_009225 small nuclear ribonucleoprotein B (Snrpb), mRNA [NM_009225] KLA 1.04 1.15 1.10 .93 1.04 .79 .73
ATP 1.13 1.30 .93 1.39 1.06 .86 .72
KLA/ATP 1.27 1.24 .83 1.57 .96 .81 .63
Snrpb2
KLA  ATP  ATP+KLA
 NM_021335 U2 small nuclear ribonucleoprotein B (Snrpb2), mRNA [NM_021335] KLA 1.23 1.20 1.24 1.27 1.00 .88 .82
ATP 1.00 .90 1.18 1.02 .98 .93 .76
KLA/ATP 1.19 1.21 1.58 1.23 1.19 .95 .72
Snrpc
KLA  ATP  ATP+KLA
 NM_011432 U1 small nuclear ribonucleoprotein C (Snrpc), mRNA [NM_011432] KLA 1.20 1.11 1.03 1.03 1.12 1.09 1.03
ATP 1.09 1.13 1.11 1.23 1.03 .95 .89
KLA/ATP 1.11 1.15 1.12 1.29 1.11 1.19 1.22
Snrpd1
KLA  ATP  ATP+KLA
 AK017788 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730525N20 product:small nuclear ribonucleoprotein D1, full insert sequence. [AK017788] KLA 1.12 1.03 1.02 1.02 .99 .96 1.01
ATP 1.11 1.05 1.14 1.03 1.07 1.21 1.05
KLA/ATP .91 1.06 1.18 1.06 1.00 1.03 1.14
Snrpd1
KLA  ATP  ATP+KLA
 NM_009226 small nuclear ribonucleoprotein D1 (Snrpd1), mRNA [NM_009226] KLA 1.10 1.05 .92 .94 .76 .73 .68
ATP 1.00 .98 1.18 1.10 .98 .90 .49
KLA/ATP .90 1.03 1.21 1.03 .92 .70 .39
Snrpd2
KLA  ATP  ATP+KLA
 NM_026943 small nuclear ribonucleoprotein D2 (Snrpd2), mRNA [NM_026943] KLA 1.10 1.11 1.00 1.09 .98 .99 .80
ATP .90 .98 1.19 1.40 1.28 1.13 .69
KLA/ATP 1.00 1.14 1.37 1.45 1.36 1.19 .64
Snrpd3
KLA  ATP  ATP+KLA
 NM_026095 small nuclear ribonucleoprotein D3 (Snrpd3), mRNA [NM_026095] KLA 1.00 1.09 .86 1.16 .77 .87 .86
ATP .77 1.06 1.12 1.18 .96 .87 .59
KLA/ATP .92 1.16 1.43 1.14 1.18 .82 .58
Snrpe
KLA  ATP  ATP+KLA
 NM_009227 small nuclear ribonucleoprotein E (Snrpe), mRNA [NM_009227] KLA 1.06 .98 .97 1.09 .95 .77 .74
ATP 1.13 1.01 1.17 1.40 1.29 .91 .66
KLA/ATP 1.14 1.16 1.18 1.23 1.28 1.02 .65
Snrpg
KLA  ATP  ATP+KLA
 NM_026506 small nuclear ribonucleoprotein polypeptide G (Snrpg), mRNA [NM_026506] KLA .84 .82 .81 .81 .70 .59 .59
ATP .95 .93 1.29 1.23 1.07 .76 .49
KLA/ATP .82 .82 1.10 1.04 1.04 .71 .34
Snw1
KLA  ATP  ATP+KLA
 NM_025507 SNW domain containing 1 (Snw1), mRNA [NM_025507] KLA 2.06 2.04 2.00 2.32 1.97 1.86 1.63
ATP 1.12 1.08 1.10 1.02 1.17 1.61 1.60
KLA/ATP 1.90 2.12 2.63 2.35 2.27 2.75 2.79
Syf2
KLA  ATP  ATP+KLA
 NM_026780 SYF2 homolog, RNA splicing factor (S. cerevisiae) (Syf2), mRNA [NM_026780] KLA 2.75 2.55 2.84 2.78 2.06 1.73 1.43
ATP 1.16 .99 1.33 3.31 1.85 1.53 1.41
KLA/ATP 2.84 3.03 4.32 5.71 4.47 2.53 2.27
Tcerg1
KLA  ATP  ATP+KLA
 NM_001039474 transcription elongation regulator 1 (CA150) (Tcerg1), mRNA [NM_001039474] KLA 1.04 1.10 1.02 .85 .88 .91 1.06
ATP .99 1.18 1.11 1.09 1.21 .79 .60
KLA/ATP 1.16 1.14 .85 .98 .75 .64 .48
Thoc1
KLA  ATP  ATP+KLA
 NM_153552 THO complex 1 (Thoc1), mRNA [NM_153552] KLA 1.22 1.21 1.09 .94 .81 .83 1.06
ATP .93 .92 .95 .85 .79 .90 .82
KLA/ATP 1.12 1.18 1.03 .90 .73 .69 .57
Thoc2
KLA  ATP  ATP+KLA
 AK040892 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530039L08 product:unclassifiable, full insert sequence. [AK040892] KLA 1.63 1.74 1.47 1.52 1.13 1.06 .96
ATP 1.06 1.07 1.24 1.02 1.11 1.31 .77
KLA/ATP 1.67 1.81 1.98 1.28 1.25 1.05 .92
Thoc2
KLA  ATP  ATP+KLA
 NM_001033422 THO complex 2 (Thoc2), mRNA [NM_001033422] KLA 1.67 1.62 1.44 1.46 1.24 1.01 1.00
ATP 1.12 1.12 1.12 1.05 1.20 1.12 .83
KLA/ATP 1.50 1.66 1.78 1.37 1.11 .86 .98
Thoc3
KLA  ATP  ATP+KLA
 NM_028597 THO complex 3 (Thoc3), mRNA [NM_028597] KLA .95 .99 .93 .97 .93 .88 .79
ATP .93 .93 .98 .95 .70 .95 .73
KLA/ATP .88 .97 1.01 .97 .80 .80 .57
Thoc4
KLA  ATP  ATP+KLA
 NM_011568 THO complex 4 (Thoc4), mRNA [NM_011568] KLA .99 .96 .87 .99 .71 .60 .60
ATP .97 .92 1.37 1.52 1.35 1.09 .45
KLA/ATP .92 .98 1.09 1.27 1.31 .85 .29
Tra2a
KLA  ATP  ATP+KLA
 AK076230 1 day pregnant adult female mammary gland cDNA, RIKEN full-length enriched library, clone:4222403J09 product:inferred: RIKEN cDNA 1500010G04 gene, full insert sequence. [AK076230] KLA 3.06 2.71 2.04 1.29 1.09 1.13 .96
ATP .68 .65 .64 .83 1.54 1.44 .91
KLA/ATP 1.55 1.39 1.06 1.13 1.67 1.66 1.14
Tra2a
KLA  ATP  ATP+KLA
 NM_198102 transformer 2 alpha homolog (Drosophila) (Tra2a), mRNA [NM_198102] KLA 4.45 4.80 4.77 4.44 1.66 .64 .76
ATP .90 .98 .92 .85 .75 1.16 .75
KLA/ATP 4.02 4.94 4.22 3.01 1.87 1.06 .78
Txnl4a
KLA  ATP  ATP+KLA
 NM_025299 thioredoxin-like 4A (Txnl4a), transcript variant 1, mRNA [NM_025299] KLA .99 .99 .98 .89 .90 .86 .98
ATP .94 1.00 1.11 1.39 1.42 1.35 1.36
KLA/ATP 1.04 .99 1.08 1.15 1.35 1.20 1.08
Txnl4a
KLA  ATP  ATP+KLA
 NM_178604 thioredoxin-like 4A (Txnl4a), transcript variant 2, mRNA [NM_178604] KLA .58 .59 .57 .51 .66 .77 1.03
ATP .87 .71 .57 .49 .78 .86 1.07
KLA/ATP .59 .49 .35 .36 .48 .67 .83
U2af1
KLA  ATP  ATP+KLA
 NM_024187 U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1 (U2af1), mRNA [NM_024187] KLA 1.12 1.10 .97 1.04 .84 .96 1.06
ATP .89 .87 1.01 .94 .96 .97 .72
KLA/ATP 1.00 1.07 1.22 .92 .95 .71 .52
U2af1l4
KLA  ATP  ATP+KLA
 NM_170760 U2 small nuclear RNA auxiliary factor 1-like 4 (U2af1l4), mRNA [NM_170760] KLA 1.04 1.07 1.08 .98 1.05 .97 1.11
ATP 1.08 1.08 .98 1.37 .96 .76 .90
KLA/ATP 1.20 1.11 1.11 1.35 1.00 .92 .94
U2af2
KLA  ATP  ATP+KLA
 NM_133671 U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 2 (U2af2), mRNA [NM_133671] KLA 1.15 1.29 1.40 1.06 1.13 1.11 1.22
ATP 1.15 1.51 1.15 1.64 1.27 .81 1.03
KLA/ATP 1.47 1.53 1.14 1.55 1.02 .89 1.05
Usp39
KLA  ATP  ATP+KLA
 NM_138592 ubiquitin specific peptidase 39 (Usp39), mRNA [NM_138592] KLA 1.21 1.17 1.38 1.27 1.17 1.18 1.56
ATP 1.18 1.22 .98 1.31 1.21 1.07 1.22
KLA/ATP 1.35 1.44 1.15 1.34 1.12 1.06 1.15
Wbp11
KLA  ATP  ATP+KLA
 NM_021714 WW domain binding protein 11 (Wbp11), mRNA [NM_021714] KLA 1.09 1.05 1.10 1.41 1.48 1.18 .99
ATP .94 .99 1.12 1.14 1.02 1.33 .92
KLA/ATP .92 .93 .90 1.13 1.07 2.02 1.30
Wdr57
KLA  ATP  ATP+KLA
 NM_025645 WD repeat domain 57 (U5 snRNP specific) (Wdr57), mRNA [NM_025645] KLA .95 .88 .82 .95 .95 .93 .85
ATP 1.02 1.00 .98 .83 .88 .97 .94
KLA/ATP .88 .93 1.05 .82 .87 1.03 .78
Xab2
KLA  ATP  ATP+KLA
 NM_026156 XPA binding protein 2 (Xab2), mRNA [NM_026156] KLA .77 .89 .85 .85 1.01 1.03 1.05
ATP 1.10 1.25 .81 1.00 .84 .97 1.09
KLA/ATP 1.01 .95 .64 .91 .76 1.14 1.15
Zmat2
KLA  ATP  ATP+KLA
 NM_025594 zinc finger, matrin type 2 (Zmat2), mRNA [NM_025594] KLA 1.04 1.01 .97 1.09 1.02 1.16 .88
ATP .91 .88 1.30 1.08 .80 1.18 1.25
KLA/ATP .89 1.00 1.39 1.19 1.18 1.27 1.46